Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |